Alliance Pharma Share Price | |
---|---|
Price | 38.60 |
Bid | 38.55 |
Ask | 38.80 |
Change | 3.45 (9.82%) |
Volume | 4,416,310 |
Open | 35.00 |
High | 38.85 |
Low | 34.55 |
Prev. Close | 35.15 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £208.59m |
Market Size | 20,000 |
52 Week High | 62.90 |
52 Week High Date | 30-May-2023 |
52 Week Low | 24.55 |
52 Week Low Date | 08-May-2024 |
# Trades | 480 |
---|---|
Vol. Sold | 2,912,072 |
Sold Value | £980.86k |
Vol. Bought | 1,332,803 |
Bought Value | £398.39k |
PE Ratio | 227.05882 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 4.381% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
23-May-24 | 16:35:11 | 38.60 | 98,023 | Sell* | 38.55 | 38.80 | 37.84k | UT Uncrossing Trade |
23-May-24 | 16:29:55 | 38.50 | 2,134 | Buy* | 38.35 | 38.50 | 821.59 | A Automatic Execution |
23-May-24 | 16:27:10 | 38.3301 | 3,100 | Sell* | 38.30 | 38.50 | 1,188 | O Ordinary |
23-May-24 | 16:26:11 | 38.488 | 1,500 | Buy* | 38.35 | 38.50 | 577.32 | O Ordinary |
23-May-24 | 16:26:03 | 38.47 | 2,599 | Buy* | 38.35 | 38.50 | 999.84 | O Ordinary |
23-May-24 | 16:25:56 | 38.4307 | 1,500 | Buy* | 38.30 | 38.50 | 576.46 | O Ordinary |
23-May-24 | 16:25:30 | 38.3301 | 100 | Sell* | 38.30 | 38.50 | 38.33 | O Ordinary |
23-May-24 | 16:25:10 | 38.33 | 1 | Sell* | 38.30 | 38.50 | 0.38 | O Ordinary |
23-May-24 | 16:24:45 | 38.35 | 185 | Sell* | 38.35 | 38.50 | 70.95 | A Automatic Execution |
23-May-24 | 16:24:45 | 38.35 | 39 | Sell* | 38.35 | 38.50 | 14.96 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions